EUCARE, which stands for European Concerted Action and Research in Epilepsy, is a joint initiative of the International Bureau for Epilepsy and the International League Against Epilepsy, supported by an unrestricted educational grant from UCB Pharma. Its aim is to raise the profile of epilepsy across Europe through educational and political actions. Activities are guided by a committee of international experts. EUCARE aims to develop strategies to improve the understanding of epilepsy, with emphasis on alleviating its social consequences; promoting exchange of knowledge between all disciplines providing care for people with epilepsy; supporting research into the evolution, investigation and management of seizure disorders; highlighting epilepsy as a public health priority among governments and health authorities.
The major focus going forward will be an observational study of the pharmacological and lifestyle consequences of newly-diagnosed epilepsy in different European countries.